Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Slow release oral morphine versus methadone for the treatment of opioid use disorder
Ján Klimas, Lauren Gorfinkel, Salvatore Giacomuzzi, et al.
BMJ Open (2019) Vol. 9, Iss. 4, pp. e025799-e025799
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder
Olivia Magwood, Ginetta Salvalaggio, Michaela Beder, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0227298-e0227298
Open Access | Times Cited: 84
Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience
Kevin Pottie, Claire Kendall, Tim Aubry, et al.
Canadian Medical Association Journal (2020) Vol. 192, Iss. 10, pp. E240-E254
Open Access | Times Cited: 80
Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern
Hannu Alho, Maurice Demattéis, Danilo Lembo, et al.
International Journal of Drug Policy (2019) Vol. 76, pp. 102616-102616
Open Access | Times Cited: 77
The opioid overdose crisis as a global health challenge
Michael Krausz, Jean N. Westenberg, Kimia Ziafat
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 4, pp. 405-412
Closed Access | Times Cited: 71
Heroin and its metabolites: relevance to heroin use disorder
Michele Stanislaw Milella, Ginevra D’Ottavio, Silvana De Pirro, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Public health messaging and harm reduction in the time of COVID-19
Mohammad Karamouzian, Cheyenne Johnson, Thomas Kerr
The Lancet Psychiatry (2020) Vol. 7, Iss. 5, pp. 390-391
Open Access | Times Cited: 59
Opioid agonist treatment for people who are dependent on pharmaceutical opioids
Suzanne Nielsen, Wai Chung Tse, Briony Larance
Cochrane library (2022) Vol. 2022, Iss. 9
Open Access | Times Cited: 30
Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations
David A. Patterson Silver Wolf, Mark S. Gold
Journal of the Neurological Sciences (2020) Vol. 411, pp. 116718-116718
Closed Access | Times Cited: 39
Investigating opioid preference to inform safe supply services: A cross sectional study
Max Ferguson, Amrit Parmar, Kristi Papamihali, et al.
International Journal of Drug Policy (2022) Vol. 101, pp. 103574-103574
Open Access | Times Cited: 25
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials
Jihoon Lim, Imen Farhat, Antonios Douros, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0266142-e0266142
Open Access | Times Cited: 25
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors
Clara Lu, Kathryn Chan, Leslie Martin, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada
Annie Foreman-Mackey, Bernie Pauly, Andrew Ivsins, et al.
Substance Abuse Treatment Prevention and Policy (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 21
Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: a systematic review and meta‐analysis
Anees Bahji, David Carlone, Josephine Altomare
Addiction (2019) Vol. 115, Iss. 8, pp. 1413-1425
Closed Access | Times Cited: 24
Management of opioid use disorder: 2024 update to the national clinical practice guideline
Igor Yakovenko, Yvette Mukaneza, Katuschia Germé, et al.
Canadian Medical Association Journal (2024) Vol. 196, Iss. 38, pp. E1280-E1290
Open Access | Times Cited: 2
Ginseng treatment improves the sexual side effects of methadone maintenance treatment
Vahid Farnia, Mostafa Alikhani, Alireza Ebrahimi, et al.
Psychiatry Research (2019) Vol. 276, pp. 142-150
Closed Access | Times Cited: 21
Medications Development for Treatment of Opioid Use Disorder
E. Andrew Townsend, S. Stevens Negus, Matthew L. Banks
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 1, pp. a039263-a039263
Open Access | Times Cited: 20
Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review
Stephanie Veazie, Katherine Mackey, Kim Peterson, et al.
Journal of General Internal Medicine (2020) Vol. 35, Iss. S3, pp. 945-953
Open Access | Times Cited: 20
Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats
E. Andrew Townsend, Bruce E. Blough, David H. Epstein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 12, pp. 2132-2139
Open Access | Times Cited: 12
Endogenous opiates and behavior: 2019
Richard J. Bodnar
Peptides (2021) Vol. 141, pp. 170547-170547
Closed Access | Times Cited: 15
Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era
Jeremy Weleff, Nicholaus J. Christian, James X. Wang, et al.
American Journal on Addictions (2024)
Open Access | Times Cited: 1
Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review
Simeon D. Kimmel, Paxton Bach, Alexander Y. Walley
Journal of General Internal Medicine (2020) Vol. 35, Iss. 8, pp. 2418-2426
Open Access | Times Cited: 12
Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial
M. Eugenia Socías, Evan Wood, Huiru Dong, et al.
Contemporary Clinical Trials (2020) Vol. 91, pp. 105993-105993
Open Access | Times Cited: 9
Retention in the Austrian opioid agonist treatment system: a national prospective cohort study
Martin Busch, Charlotte Klein, Alfred Uhl, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Uptake of slow‐release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder
Thomas D. Brothers, John F. Fraser, Emily MacAdam, et al.
Drug and Alcohol Review (2021) Vol. 41, Iss. 2, pp. 430-434
Open Access | Times Cited: 9
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series
Olivia Brooks, Joan C.Y. Ng, Sarah Ickowicz
Journal of Addiction Medicine (2023) Vol. 17, Iss. 4, pp. e240-e245
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top